Constellation Pharmaceuticals
Biopharmaceutical company focused on developing novel therapeutics that target disease-related gene expression through epigenetic modulation. Acquired by MorphoSys in 2021.
Location
Cambridge, Massachusetts, USA
Founded
2008
Categories
biotech, pharmaceuticals, epigenetics, oncology, hematology
